This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

FINAL SAVINGS ENG IN

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
10 - 12 June, 2025
Congress CenterBasel Switzerland

Victor Diaz Cortes, PhD
Research Director at OneChain Immunotherapeutics S.L.
Speaker

Profile

Dr. Víctor M. Díaz holds a PhD in Biochemistry and serves as Research Director at OneChain Immunotherapeutics (OCI), where he leads the development of innovative CAR-T cell therapies for hematological cancers and solid tumors. With a strong background in academic and translational research, Dr. Díaz has played a key role in advancing CAR candidates through orphan drug designations, clinical trial authorizations, and the filing of multiple patents. He currently oversees a multidisciplinary team at OCI focused on both autologous and allogeneic strategies for cancer treatment.

Agenda Sessions

  • Advancing CAR-T Engineering for T-ALL with CHO-Derived Recombinant scFvs and Anti-Idiotype Antibodies: Innovations and Applications

    11:50